ÂÜÀòÂÒÂ×

Johanna Asklin is a seasoned professional in the life sciences sector, currently serving as General Partner at FÃ¥hraeus Startup & Growth since February 2023, where the focus is on investing in early-stage life science and technology companies. Previous roles include Board Member at Arcede Pharma, which specializes in developing drug candidates for chronic obstructive pulmonary disease and severe asthma, and holding dual positions as Director of Client Partnerships and Director of Operations at SAGA Diagnostics, a company focused on personalized cancer medicine. Johanna's extensive experience also includes leadership roles at LU Innovation, SmiLe Incubator, and SARomics Biostructures, as well as a Business Development Manager position at Statens Serum Institut, emphasizing vaccines and diagnostics. Johanna holds both a PhD in Medicine (Immunology) and an MSc in Pharmaceutical Biomedicine from the University of Gothenburg.